Redeye comments on the announcement of sales of the Nevisense device to NIH as a research tool on th...
Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) publicerade den 26 september 20...
Redeye comments on the news that Ngenic and Svea Solar entered a strategic partnership agreement wor...
Redeye comments on the steps in the US to expand the footprint.
Redeye comments on Optomed’s profit warning, where the company expects its revenues to decrease comp...
Redeye embraces the positive results from the SOLARIO trial, and we argue that the company has ticke...
Redeye comments on Iconovo’s announced rights issue of units.
Redeye comments on Modelon’s recently announced cost reduction program and organizational changes.
Redeye comments on last night's selling from two of Truecaller's largest shareholders (Kleiner Perki...
TCECUR Sweden AB (”TCECUR” eller ”Koncernen”) meddelade den 24 september år 2024 att Jacob Philipsso...
Q3 report due 24 October, we evaluate D2C potential We forecast net sales of SEK 186m, EBITA of SEK ...
Redeye provides a short comment on Episurf's announcement about the revised estimated timeline for F...
Redeye comments on Arise’s divestment of a 40MW battery project for a total consideration of SEK30m ...
Cibus, which raised EUR ~82m new equity two weeks ago to fund growth, announced after market close o...
Ramlösa shipping AB (”Ramlösa” eller ”Bolaget”) är ett investmentbolag med exponering mot sjöfartsma...
